1 . Abubakar, I. I., Tillmann, T., & Banerjee, A. ,2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385(9963), 117-171.
2. Chi, K.N., Siu, L.L., Hirte, H., Hotte, S.J., Knox, J., Kollmansberger, C., Gleave, M., Guns, E., Powers, J., Walsh, W. and Tu, D., 2008. A phase I study of OGX-011, a 2′-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer. Clinical Cancer Research, 14(3), pp.833-839.
3. Debruyne, E.N., Vanderschaeghe, D., Van Vlierberghe, H., Vanhecke, A., Callewaert, N. and Delanghe, J.R., 2010. Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clinical chemistry, 56(5), pp.823-831.
4. Ehsani Ardakani, M. J., Safaei, A., Arefi Oskouie, A., Haghparast, H., Haghazali, M., Mohaghegh Shalmani, H., … Zali, M. R. , 2016. Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks. Gastroenterology and Hepatology From Bed to Bench, 9(Suppl1), S14–S22.
5. Gangadharan, B., Antrobus, R., Dwek, R. A., & Zitzmann, N. ,2007. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clinical chemistry, 53(10), 1792-1799.
6. Jung, G.S., Kim, M.K., Jung, Y.A., Kim, H.S., Park, I.S., Min, B.H., Lee, K.U., Kim, J.G., Park, K.G. and Lee, I.K., 2012. Clusterin attenuates the development of renal fibrosis. Journal of the American Society of Nephrology, 23(1), pp.73-85.
7.Koltai, T., 2014. Clusterin: a key player in cancer chemoresistance and its inhibition. OncoTargets and therapy, 7, p.447.
8 . Lin, C.C., Tsai, P., Sun, H.Y., Hsu, M.C., Lee, J.C., Wu, I.C., Tsao, C.W., Chang, T.T. and Young, K.C., 2014. Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production. Journal of hepatology, 61(5), pp.984-993.
-9. Malaguarnera, G., Giordano, M., Paladina, I., Berretta, M., Cappellani, A. and Malaguarnera, M., 2010. Serum markers of hepatocellular carcinoma. Digestive diseases and sciences, 55(10), pp.2744-2755.
10. Norouzinia, M., Asadzadeh, H., Shalmani, H.M., Al Dulaimi, D. and Zali, M.R., 2012. Clinical and histological indicators of proximal and distal gastric cancer in eight provinces of Iran. Asian Pacific Journal of Cancer Prevention, 13(11), pp.5677-5679
11. Sansanwal, P., Li, L. and Sarwal, M.M., 2015. Inhibition of intracellular clusterin attenuates cell death in nephropathic cystinosis. Journal of the American Society of Nephrology, 26(3), pp.612-625.
12 . Wang, Y., Liu, Y.H., Mai, S.J., He, L.J., Liao, Y.J., Deng, H.X., Guan, X.Y., Zeng, Y.X., Kung, H.F. and Xie, D., 2010. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. Journal of gastroenterology and hepatology, 25(6), pp.1123-1128.